Sino Medical Sciences Technology Inc.'s high P/S ratio is alarming considering its medium-term revenue decline and projected industry growth. If these trends persist, the share price may drop, adjusting the P/S ratio to a more reasonable level, posing a substantial risk to shareholders and potential investors.
赛诺医疗股票讨论区
暂无评论